0000315066-25-002110.txt : 20250806
0000315066-25-002110.hdr.sgml : 20250806
20250806121418
ACCESSION NUMBER: 0000315066-25-002110
CONFORMED SUBMISSION TYPE: SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20250806
DATE AS OF CHANGE: 20250806
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Structure Therapeutics Inc.
CENTRAL INDEX KEY: 0001888886
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
EIN: 981480821
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SCHEDULE 13G/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-93902
FILM NUMBER: 251188466
BUSINESS ADDRESS:
STREET 1: 611 GATEWAY BLVD SUITE 223
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (628) 229-9277
MAIL ADDRESS:
STREET 1: 611 GATEWAY BLVD SUITE 223
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: ShouTi Inc.
DATE OF NAME CHANGE: 20211019
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: FMR LLC
CENTRAL INDEX KEY: 0000315066
STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000]
ORGANIZATION NAME:
EIN: 043532603
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SCHEDULE 13G/A
BUSINESS ADDRESS:
STREET 1: 245 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6175706339
MAIL ADDRESS:
STREET 1: 245 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02210
FORMER COMPANY:
FORMER CONFORMED NAME: FMR CORP
DATE OF NAME CHANGE: 19920717
SCHEDULE 13G/A
1
primary_doc.xml
SCHEDULE 13G/A
0000315066-23-002177
0000315066
XXXXXXXX
LIVE
4
COMMON STOCK
06/30/2025
0001888886
STRUCTURE THERAPEUTICS INC
86366E106
611 GATEWAY BLVD
SUITE 223
SOUTH SAN FRANCISCO
CA
94080
Rule 13d-1(c)
FMR LLC
DE
19946433.00
0.00
19946433.00
0.00
19946433.00
11.6
HC
Abigail P. Johnson
X1
0.00
0.00
19946433.00
0.00
19946433.00
11.6
IN
STRUCTURE THERAPEUTICS INC
611 GATEWAY BLVD,SUITE 223,SOUTH SAN FRANCISCO,CA,USA,94080
FMR LLC
245 Summer Street, Boston, Massachusetts 02210
Not applicable
Y
19946433.00
11.6
Please see the responses to Items 5 and 6 on the cover page.
0.00
19946433.00
0.00
Y
N
N
One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the COMMON STOCK of STRUCTURE THERAPEUTICS INC. No one other person's interest in the COMMON STOCK of STRUCTURE THERAPEUTICS INC is more than five percent of the total outstanding COMMON STOCK.
N
See attached Exhibit 99.
Y
Y
N
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
Please see Exhibit 99 for 13d-1(k) (1) agreement.
FMR LLC
Richard Bourgelas
Duly authorized under Power of Attorney effective as of May 23, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries*
08/05/2025
Abigail P. Johnson
Richard Bourgelas
Duly authorized under Power of Attorney effective as of May 23, 2023, by and on behalf of Abigail P. Johnson*
08/05/2025
*This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on August 8, 2023, accession number: 0000315066-23-002397.
EX-99
2
exhibit99.txt
Exhibit 99
Pursuant to the instructions in Item 7 of Schedule 13G, the following table
lists the identity and Item 3 classification, if applicable, of each relevant
entity that beneficially owns shares of the security class being reported on
this Schedule 13G.
Entity ITEM 3 Classification
Crosby Advisors LLC N/A
FIAM LLC IA
Fidelity Institutional Asset Management Trust Company BK
Fidelity Management & Research Company LLC * IA
Fidelity Management Trust Company BK
IMPRESA MANAGEMENT LLC IA
* Entity beneficially owns 5% or greater of the outstanding shares of the
security class being reported on this Schedule 13G.
Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer
of FMR LLC.
Members of the Johnson family, including Abigail P. Johnson, are the
predominant owners, directly or through trusts, of Series B voting common
shares of FMR LLC, representing 49% of the voting power of FMR LLC. The
Johnson family group and all other Series B shareholders have entered into a
shareholders' voting agreement under which all Series B voting common shares
will be voted in accordance with the majority vote of Series B voting common
shares. Accordingly, through their ownership of voting common shares and the
execution of the shareholders' voting agreement, members of the Johnson family
may be deemed, under the Investment Company Act of 1940, to form a controlling
group with respect to FMR LLC.
This filing reflects the securities beneficially owned, or that may be deemed
to be beneficially owned, by FMR LLC, certain of its subsidiaries and
affiliates, and other companies (collectively, the "FMR Reporters"). This
filing does not reflect securities, if any, beneficially owned by certain
other companies whose beneficial ownership of securities is disaggregated from
that of the FMR Reporters in accordance with Securities and Exchange
Commission Release No. 34-39538 (January 12, 1998).
RULE 13d-1(k)(1) AGREEMENT
The undersigned persons, on August 5, 2025, agree and consent to the joint
filing on their behalf of this Schedule 13G in connection with their
beneficial ownership of the COMMON STOCK of STRUCTURE THERAPEUTICS INC at June
30, 2025.
FMR LLC
By /s/ Richard Bourgelas
Richard Bourgelas
Duly authorized under Power of Attorney effective as of May 23, 2023, by and
on behalf of FMR LLC and its direct and indirect subsidiaries*
Abigail P. Johnson
By /s/ Richard Bourgelas
Richard Bourgelas
Duly authorized under Power of Attorney effective as of May 23, 2023, by and
on behalf of Abigail P. Johnson*
*This power of attorney is incorporated herein by reference to Exhibit 24 to
the Schedule 13G filed by FMR LLC on August 8, 2023, accession number:
0000315066-23-002397.